Hinai, Y <br/><br/>
Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.  [electronic resource] 

 -  Journal of clinical pharmacy and therapeutics  Dec 2013 
 - 498-503 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2710 
<br/><br/><label>Standard No.: </label>10.1111/jcpt.12097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Antineoplastic Agents--adverse effects<br/>Blood Cell Count<br/>Chemoradiotherapy<br/>Cisplatin--adverse effects<br/>DNA--genetics<br/>Electrolytes--blood<br/>Esophageal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--therapeutic use<br/>Genotype<br/>Glomerular Filtration Rate<br/>Humans<br/>Kidney Diseases--chemically induced<br/>Kidney Function Tests<br/>Male<br/>Middle Aged<br/>Organic Cation Transport Proteins--genetics<br/>Organic Cation Transporter 2<br/>Regression Analysis